Inaugural Psychiatry Summit 2022

Click here to register now on the website.

The Inaugural Psychiatry Summit 2022 includes 3 full days of live, virtual, cutting edge programs! Early bird pricing of $149 available for a limited time (regular rate $199). The summit sets the standard for timely, unbiased, evidence-based education from the world’s leading experts.

Join psychiatrists, NPs, PAs, and other healthcare professionals from around the world for this unique virtual opportunity to enhance knowledge and improve patient outcomes. Engage with U.S.-based and international experts as they discuss the latest advances in the diagnosis and treatment of a wide range of psychiatric illnesses, debate controversies in the field and share their clinical pearls. Earn up to 15 hours of CME/CE credit.

Agenda

Inaugural Psychiatry Summit
March 24 – 26, 2022
Live Virtual Webinar
Tentative Agenda
Please note: All times are ET

Day 1 - Thursday, March 24, 2022 

9:45 – 10:00 AM: Opening Remarks by Scientific Committee Member - Roger S. McIntyre, MD, FRCPC – University of Toronto

10:00 – 11:00 AM: Keynote Address - The Pursuit of Mental Health Equity by Patrick J. Kennedy – Former Congressman (D-RI)

-5 min break-

11:05 – 12:05 PM: Pharmacological Strategies for Treatment-Resistant Depression - Siegfried Kasper, MD – Medical University of Vienna

-5 min break-

12:10 – 1:10 PM: Non-Accredited CE Educational Session

-25 min meal break-

1:35 – 2:35 PM: Accredited CE Satellite Symposium

-5 min break-

2:40 – 3:40 PM: Non-Accredited CE Educational Session

3:40 – 4:40 PM: Poster Hall

4:40 – 5:40 PM: New Mechanisms-New Medications for Schizophrenia: Jonathan M. Meyer, MD – University of California, San Diego

-5 min break-

5:45 – 6:45 PM: Why Do Schizophrenia Patients Relapse and What Should We Do? – John M. Kane, MD – Hofstra/Northwell

6:45 – 7:00 PM: Closing Remarks by Scientific Committee Member – John M. Kane, MD – Hofstra/Northwell

 

Day 2 - Friday, March 25, 2022

9:45 – 10:00 AM: Opening Remarks by Scientific Committee Member – Alan F. Schatzberg, MD – Stanford University School of Medicine

10:00 – 11:00 AM: Potential Drugs of Abuse as Antidepressants? – Alan F. Schatzberg, MD – Stanford University School of Medicine

-5 min break-

11:05 – 12:05 PM: Targeting Anxiety Symptoms in Mood Disorder Patients – Michael Thase, MD – University of Pennsylvania

-5 min break-

12:10 – 1:10 PM: Non-Accredited CE Educational Session

-25 min break-

1:35 – 2:35 PM: Accredited CE Satellite Symposium

-5 min break-

2:40 – 3:40 PM: Non-Accredited CE Educational Session

3:40 – 4:40 PM: Poster Hall

4:40 – 5:40 PM: Accredited CE Satellite Symposium

-5 min break-

5:45 – 6:45 PM: Treatment of Bipolar-Unipolar as a Spectrum Disorder – Joseph Goldberg, MD – Mt. Sinai New York

6:45 – 7:00 PM: Closing Remarks by Scientific Committee Member – Joseph Goldberg, MD – Mt. Sinai New York

Day 3 - Saturday, March 26, 2022

9:45 – 10:00 AM: Opening Remarks by Scientific Committee Member – Manpreet K. Singh, MD, MS – Stanford University  

10:00 – 11:00 AM: Fireside Chat: Mood Disorders in Special Populations – Manpreet K. Singh, MD, MS – Stanford University and Thomas L. Schwartz, MD – SUNY Upstate Medical University

-5 min break-

11:05 – 12:05 PM: CME Satellite Symposium

-5 min break-

12:10 – 1:10 PM: Non-Accredited CE Educational Session

-25 min meal break-

1:35 – 2:35 PM: Accredited CE Satellite Symoisum

-5 min break-

2:40 – 3:40 PM: Non-Accredited CE Educational Session

3:40 – 4:40 PM: Poster Hall

4:40 – 5:40 PM: Treatment Resistant Bipolar Disorders – Roger S. McIntyre, MD, FRCPC – University of Toronto

-5 min break-

5:45 – 6:45 PM: Targeting Attentional Complaints Across DSM-5 Categories: A Transdiagnostic Approach – Gregory W. Mattingly, MD – Washington University

6:45 – 7:00 PM: Closing Remarks by Scientific Committee Member – Roger S. McIntyre, MD, FRCPC

Faculty

Faculty
Siegfried Kasper, MD

Professor of Psychiatry
Emeritus Chairman, 
Department of Psychiatry and Psychotherapy
Medical University of Vienna
Vienna, Austria

Faculty
Patrick J. Kennedy

Former Congressman (D-RI);
Founder, The Kennedy Forum;
Co-Founder, One Mind

Faculty
Greg Mattingly, MD

Associate Clinical Professor
Psychiatry, Psychopharmacology
Washington University School of Medicine
St Louis, Missouri
President
St Charles Psychiatry Associates
St Charles, Missouri

Faculty
Jonathan Meyer, MD

Clinical Professor
Psychiatry
University of California, San Diego
La Jolla, California
Psychopharmacology Consultant
California Department of State Hospitals
Sacramento, California

Faculty
Thomas L. Schwartz, MD

Professor of Psychiatry and Director of Adult Psychiatric Clinical Services
SUNY Upstate Medical University

Faculty
Michael E. Thase, MD

Professor of Psychiatry
Department of Psychiatry
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Scientific Committee
Joseph Goldberg, MD

Clinical Professor of Psychiatry
Department of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Scientific Committee
John M. Kane, MD

Vice President for Behavioral Health Services
Northwell Health
Chairman of Psychiatry
Zucker Hillside Hospital
Queens, New York
Chairman of Psychiatry
Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell
Hempstead, New York

Scientific Committee
Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
Department of Psychiatry/Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
Department of Psychiatry
Toronto, Canada

Scientific Committee
Alan F. Schatzberg, MD

Kenneth T. Norris, Jr., Professor
Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Scientific Committee
Manpreet K. Singh, MD, MS

Associate Professor and Akiko Yamazaki and Jerry Yang Faculty
Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Program Overview
The primary purpose of this activity is to improve participants’ competence in addressing the most important and most current challenges in the treatment of psychiatric illness by providing a focused upate on recent advances and key issues.

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of psychiatric illness.

Target Audience
This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • TBD

Accreditation

**Credit/Contact hours are subject to change**

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 15.0 AMA PRA Category 1 CreditsTM. Psysicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 15.0 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 15.0 contact hours (1.5 CEUs) of the Accreditation Council for Pharmacy Education. UAN will be specific to each topic.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 15.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 15.0 continuing education credits for psychologists

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC (CCO) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CCO maintains responsibility for this course. Social workers completing this course will receive 15.0 continuing education credits.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.